- Presentations
- 3
- Markets
- 1
Nucala is a brand of Mepolizumab marketed by GlaxoSmithKline, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Mepolizumab
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 100 mg/1 mL injection, 40 mg/0.4 mL injection, 100 mg/mL powder for injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Nucala 100 mg/1 mL injectionSubcutaneous Cold chain | GlaxoSmithKline | US FDA | Available on request |
| Nucala 40 mg/0.4 mL injectionSubcutaneous Cold chain | GlaxoSmithKline | US FDA | Available on request |
| Nucala 100 mg/mL powder for injectionSubcutaneous Cold chain | GlaxoSmithKline | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Nucala
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.